ADAMIS PHARMACEUTICALS
Adamis Pharmaceuticals Corporation (ADMP) is a biopharmaceutical company that engages in the development and commercialization of specialty pharmaceutical and biotechnology products in the therapeutic areas of respiratory disease, allergy, oncology, and immunology. In its specialty pharmaceutical pipeline, ADMP is developing low-cost therapeutic alternatives for the treatment of anaphylaxis, asthma, chronic obstructive pulmonary disease (COPD), and allergic rhinitis. Within the company's biotechnology pipeline are a novel cell-based therapeutic cancer vaccine and three drug candidates for the treatment of prostate cancer.
ADAMIS PHARMACEUTICALS
Industry:
Biopharma Biotechnology Therapeutics
Founded:
2006-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.adamispharmaceuticals.com
Total Employee:
11+
Status:
Active
Contact:
8584610842
Email Addresses:
[email protected]
Total Funding:
67.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics LetsEncrypt WordPress Wordpress Plugins Mobile Non Scaleable Content Nginx
Similar Organizations
AffyImmune Therapeutics
AffyImmune Therapeutics is a biopharmaceutical company developing genetically engineered immune cells to fight cancer.
Alios BioPharma
Alios BioPharma is a biotechnology company developing novel medicines for the treatment of viral diseases.
Alladapt Immunotherapeutics
Alladapt Immunotherapeutics is a privately held biopharmaceutical company developing prescription therapeutics targeting food allergy.
Alvine Pharmaceuticals
Alvine Pharmaceuticals is a biotechnology company developing therapeutics for autoimmune and inflammatory diseases.
Arno Therapeutics
Arno Therapeutics is a biopharmaceutical company developing innovative products for the treatment of cancer patients.
Atriva Therapeutics
Atriva is a biopharmaceutical company which aims to develop new antiviral therapies against different respiratory viral infections.
BioVaxys
BioVaxys is a clinical stage biotechnology company developing immunotherapeutic cancer vaccines targeting melanoma.
Boston Immune Technologies & Therapeutics
This company is a Boston-based biopharmaceutical company developing immune-based approaches.
CTI BioPharma
CTI BioPharma is a biopharmaceutical company developing oncology products for the treatment of cancer.
Chiasma
Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.
Civitas Therapeutics
Civitas Therapeutics is a biopharmaceutical company that focuses on developing pulmonary delivery therapies.
CureVac
CureVac is a clinical-stage biopharmaceutical company that provides prophylactic and therapeutic application of messenger RNA.
DiaMedica
DiaMedica is a biopharmaceutical company focused on developing innovative treatments for stroke.
Elixiron Immunotherapeutics
Elixiron Immunotherapeutics is a company developing therapeutics for cancer, rare, and inflammatory disorders
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Faraday Pharmaceuticals
Faraday Pharmaceuticals is an early-stage therapeutics company focused on developing novel therapies to treat ischemia-reperfusion injury.
Genelux
Genelux, a clinical-stage biopharmaceutical company, develops diagnostic and therapeutic solutions for cancer and inflammatory diseases.
Idun Pharmaceuticals
IDUN Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of human therapeutics to control
Igenica
Igenica is a biopharmaceutical company developing antibody-based therapeutics for the treatment of cancer.
Intensity Therapeutics
Intensity Therapeutics is a biopharmaceutical company that provides chemotherapy treatment for cancer patients.
La jolla Pharmaceutical
La Jolla Pharmaceutical is a biopharmaceutical company that is focused on innovative therapeutics for chronic organ failure and cancer.
Loxo Oncology
Loxo Oncology is a biopharmaceutical company focused on targeted cancer therapies for genetically-defined patient populations.
MATINAS BIOPHARMA
A clinical-stage biopharmaceutical company identifying and developing therapeutics for the treatment of fungal and bacterial infections.
Moerae Matrix
Moerae Matrix is a biopharmaceutical company developing targeted therapeutics for fibrotic diseases.
NanoViricides
NanoViricides is a nano-biopharmaceutical company that develops therapeutics for patients suffering from life-threatening viral infections.
Neuren Pharmaceuticals
Neuren Pharmaceuticals is a biopharmaceutical company developing drugs for the treatment of brain injuries and neurodegeneration.
NexImmune
NexImmune is a biopharmaceutical company developing novel immuno-therapeutics based on the proprietary artificial immune technology.
Otonomy
Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
SAJE Pharma
SAJE Pharma is a bio-pharmaceutical company developing therapeutic agents for respiratory diseases.
Sorriso Pharmaceuticals
Sorriso Pharmaceuticals is a biotech firm developing disease-modifying antibodies for the treatment of inflammatory diseases.
SpringWorks Therapeutics
SpringWorks Therapeutics is a biopharmaceutical company that develops medicines for patients with severe rare diseases and cancer.
Stelis Biopharma
Stelis Biopharma is a biopharmaceutical company that delivers affordable treatments to patients in both emerging and developed markets.
Thesan Pharmaceuticals
Thesan Pharmaceuticals is a preclinical biopharmaceutical company developing novel therapeutics for skin disorders.
Transition Therapeutics
Transition Therapeutics is a biopharmaceutical company developing novel therapeutics for disease indications with large markets.
Triana Biomedicines
Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease.
Umoja Biopharma
Umoja Biopharma is a biopharmaceutical company developing next-generation immunotherapies intended to combat cancer.
Vigeo Therapeutics
Vigeo Therapeutics is a biopharmaceutical company developing novel therapeutic agents intended to treat advanced malignant tumors.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2016-03-29 | US Compounding | US Compounding acquired by Adamis Pharmaceuticals | N/A |
| 2008-02-12 | Cellegy Pharmaceuticals | Cellegy Pharmaceuticals acquired by Adamis Pharmaceuticals | N/A |
Official Site Inspections
http://www.adamispharmaceuticals.com Semrush global rank: 1.97 M Semrush visits lastest month: 10.87 K
- Host name: 227.102.198.104.bc.googleusercontent.com
- IP address: 104.198.102.227
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Adamis Pharmaceuticals"
Adamis Pharmaceuticals - Crunchbase Company Profile & Funding
Adamis Pharmaceuticals is a clinical-stage neuro-biotechnology company focused on the development and commercialization of potential blockbuster products for the treatment of a …See details»
Adamis Pharmaceuticals Announces Closing of the Merger with …
May 25, 2023 Adamis Pharmaceuticals Corporation. DMK CEO, Ebrahim (Eboo) Versi, MD, PhD, named CEO and Chairman of the combined company. Combined company will have …See details»
Adamis Pharmaceuticals - Craft
May 18, 2022 Adamis Pharmaceuticals $4.76 m in annual revenue in FY 2022. See insights on Adamis Pharmaceuticals including office locations, competitors, revenue, financials, …See details»
Adamis Pharmaceuticals Corporation - ContactOut
Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) is a specialty biopharmaceuticals company primarily focused on developing and commercializing products in various therapeutic …See details»
Adamis Pharmaceuticals Corporation | VentureRadar
Adamis Pharmaceuticals Corporation is a specialty biopharmaceutical company primarily focused on developing and commercializing products in various... ... Find out ...See details»
Adamis Pharmaceuticals - PitchBook
Adamis Pharmaceuticals General Information Description. DMK Pharmaceuticals Corp Formerly Adamis Pharmaceuticals Corp is a specialty biopharmaceutical company focused on …See details»
Adamis Pharmaceuticals Corporation - Overview, News ... - ZoomInfo
Adamis Pharmaceuticals Announces Reverse Stock Split SAN DIEGO, May 19, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage …See details»
Adamis Pharmaceuticals - Products, Competitors, Financials, …
Apr 8, 2023 Adamis Pharmaceuticals (NASDAQ: ADMP) is a specialty biopharmaceutical company that provides solutions for patients, physicians, and healthcare organizations in the …See details»
Adamis Pharmaceuticals Reports Full Year 2021 Financial
SAN DIEGO, March 31, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and commercializing specialty …See details»
Adamis Pharmaceuticals Reports Full Year 2022 Financial Results …
Mar 16, 2023 Management to host webcast/conference call today at 2 p.m. PT / 5 p.m. ETSAN DIEGO, March 16, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation …See details»
Adamis Pharmaceuticals Provides Business Update - GlobeNewswire
SAN DIEGO, June 01, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and commercializing specialty …See details»
Adamis Sends Letter to Stockholders Regarding Its Strategic Focus …
Jun 28, 2021 Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today issued the below letter to stockholders. June 28, 2021 Dear Stockholder, The Board of DirectorSee details»
Adamis Pharmaceuticals Schedules Financial Results
Nov 19, 2021 The Company’s press release concerning its financial results will be available after 1 p.m. Pacific Time on November 22, 2021 and on its website at …See details»
Adamis Pharmaceuticals Reports Full Year 2021 Financial Results …
Adamis Pharmaceuticals Corporation. Management to host webcast/conference call today at 2 p.m. PT / 5 p.m. ET. SAN DIEGO, March 31, 2022 (GLOBE NEWSWIRE) -- Adamis …See details»
Adamis Pharmaceuticals Reports Third Quarter 2022 Financial …
Nov 14, 2022 Management to host webcast/conference call today at 2:00 p.m. PT / 5:00 p.m. ETSAN DIEGO, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation …See details»
Adamis Files Definitive Proxy Statement and Sends Letter to ...
Jun 14, 2021 SAN DIEGO--(BUSINESS WIRE)--Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that it has filed its definitive proxy statement with the U.S. …See details»
Adamis Pharmaceuticals Announces Third Quarter 2021
SAN DIEGO, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and commercializing specialty …See details»
Adamis Pharmaceuticals Provides Business Update - Yahoo Finance
Jun 1, 2021 NDA for ZIMHI™ submitted to the FDA; Phase 2/3 clinical trial preparation initiated for Tempol for treatment of COVID-19SAN DIEGO, June 01, 2021 (GLOBE NEWSWIRE) -- …See details»
Adamis Pharmaceuticals: It's Now Or Never - Seeking Alpha
Dec 2, 2021 Adamis Pharmaceuticals recently received FDA approval for its intramuscular injection naloxone product ZIMHI.This approval has been a long time coming and is the …See details»
Adamis Provides Update on Clinical Trial Start-Up Progress for …
Jun 11, 2021 Adamis is carrying out these activities with a large clinical research organization (CRO). Commenced activities include site identification and initiation, data base production, …See details»